Syensqo's Remarkable Fourth Quarter and Full Year 2024 Performance
Syensqo recently announced its highlights for the fourth quarter and full year of 2024, showcasing impressive growth in a challenging market landscape. This performance reflects the company's resilience and strategic vision.
Quarter Four Achievements
During Q4 of 2024, Syensqo achieved net sales of €1.6 billion, marking a 2% increase year-on-year. This growth was largely attributed to higher volumes, despite facing a slight decline in pricing. Additionally, it’s worth noting that sequentially, pricing saw a 1% increase compared to Q3 of the same year.
Financial Highlights from Q4
- Gross profit reached €482 million, remaining stable year-on-year, which translates to a gross margin of 30.2%.
- The underlying EBITDA stood at €298 million, showcasing a 5% organic growth year-on-year, with the EBITDA margin expanding to 18.6%.
- Operating cash flow surged by an impressive 77% year-on-year, amounting to €345 million, while free cash flow reached €159 million.
- Furthermore, the company initiated a share buyback program, repurchasing and cancelling 843,000 shares worth €64 million.
Full Year 2024 in Review
For the entirety of 2024, Syensqo reported net sales of €6.6 billion. Despite experiencing an overall decline of 3% year-on-year, there was a notable recovery in net sales momentum during the latter half of the year, with significant growth within the Composite Materials sector.
Key Metrics for FY 2024
- Gross profit totaled €2.2 billion with a gross margin of 33.8%.
- The underlying EBITDA was €1.4 billion, aligning with the company's expectations, and the EBITDA margin recorded at 21.5%.
- Syensqo reported a net profit of €553 million, alongside an operating cash flow of €841 million and a free cash flow of approximately €390 million.
- The balance sheet demonstrates stability, with a net debt of €1.86 billion and a leverage ratio of 1.3x.
- Increased shareholder returns were on the agenda, highlighted by a €300 million share buyback program and a proposed dividend of €1.62 for 2024.
Insights from the CEO
Dr. Ilham Kadri, CEO of Syensqo, remarked on the company’s milestone achievements in 2024. She highlighted the firm’s strategic focus and enhanced understanding of customer needs, which are instrumental in driving innovation and improving market performance.
“We experienced year-on-year EBITDA growth alongside a robust cash flow despite facing economic fluctuations. Moving into 2025, we will continue focusing on strategies we can control, refining capital allocation, and working to unlock further value,” stated Kadri.
2025 Outlook
Looking ahead, Syensqo anticipates ongoing macroeconomic uncertainty impacting demand across various markets in 2025. Nevertheless, the company plans to leverage its strong financial foundation to accelerate initiatives focused on cost savings, innovation, and sustainable investments.
Key growth drivers are expected to be within the Composite Materials segment, capitalizing on strong underlying demand and diverse customer programs. For Specialty Polymers, sales are projected to remain approximately stable compared to 2024, driven primarily by sectors like Healthcare and Food Packaging.
The company aims to realize over €200 million in cost savings by 2026, enhancing profitability in the coming years.
Frequently Asked Questions
What are Syensqo's net sales for Q4 2024?
Syensqo reported net sales of €1.6 billion in Q4 2024, representing a 2% year-on-year increase.
What was the gross profit margin in FY 2024?
The gross profit margin for Syensqo in FY 2024 was 33.8%.
How much was the underlying EBITDA for Q4 2024?
The underlying EBITDA for Q4 2024 stood at €298 million, indicating a 5% organic growth compared to the previous year.
What future initiatives is Syensqo focusing on?
For 2025, Syensqo is prioritizing cost savings, enhancing profitability, and exploring growth opportunities in strategic regions.
What dividend has been proposed for FY 2024?
The Board of Directors proposed a dividend payment of €1.62, reflecting a payout ratio of 31%.
